About this trial
Proximal junctional kyphosis (PJK) is a common post-operative radiographic finding after surgery for adult spinal deformity (ASD) patients. Although the clinical relevance of isolated PJK is unclear, PJK can progress to symptomatic proximal junctional failures which requires a large revision surgery. Currently, post-operative bracing with a thoracolumbosacral orthosis (TLSO) is common practice after spinal deformity surgery, however the efficacy of this in preventing PJK is unknown. This multi-center randomized control trial identified 84 patients undergoing thoracolumbosacral fusion for ASD and plans to study the efficacy of a novel post-operative TLSO in preventing the development of PJK as defined by the proximal junctional angle on 6-month post-operative X-rays.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
30-75-years-old
Undergoing primary thoracolumbosacral fusion for ASD with an upper instrumented vertebrae (UIV) between T8-L2 and lower instrumented vertebrae (LIV) of S1 or the ilium.
Disqualifiers
Osteoporosis (defined as a T-score <-2.5 at the time of surgery)
Body mass index (BMI) >35 kg/m2
Revision fusions
Fusions for trauma
Trial design
Parallel
Treatments tested in this trial
Align PJK™ TLSO brace
DevicePatients will get randomized to receiving and wearing a back brace for 6 weeks postoperatively.
Standard of Care
Other interventionPatients will receive the standard of care postoperative instructions without a brace
Treatment groups
Trial outcomes
Primary outcomes
The incidence of proximal junctional kyphosis development
As defined by a proximal junctional angle both ≥10° and 10°greater than pre-operative values.
Secondary outcomes
Change in patient reported outcome measures
VAS leg pain, and VAS back pain (scale of 0-10). 0= no pain; 10=worst possible pain
Change in patient reported outcome measures
Oswestry Disability Index (0-20% minimal disability; 21-40% moderate disability; 41-60% severe disability; 61-80 cripple, pain impinges on all aspects of life; 81-100% patients are bed bound)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Hospital for Special Surgery, New York
Lead sponsor
Aspen Medical Products
Collaborator